Literature DB >> 12234671

Multiple splice variants of Par3 and of a novel related gene, Par3L, produce proteins with different binding properties.

Lin Gao1, Ian G Macara, Gérard Joberty.   

Abstract

The partitioning-defective 3 (par3) gene encodes a protein with three postsynaptic density90/DiscslargeA/ZO-1 (PDZ) domains that is required for cell polarity establishment in metazoans. Par3 is a component of a protein complex that can include Cdc42-GTP, Par6 and atypical protein kinase Cs (aPKCs). We now describe the identification of a related human gene, Par3L. Both Par3L and Par3 are expressed as numerous alternatively spliced variants. Although Par3 expression appears to be ubiquitous, that of Par3L is more restricted. Multiple variants are often expressed simultaneously within a specific cell type or tissue. Although all of the Par3L/Par3 isoforms can associate with tight junctions in epithelial cells, they show different binding properties. No Par3L isoforms and only a subset of Par3 isoforms detectably bind aPKCs. These data suggest that aPKC binding or phosphorylation is not required for targeting of Par3/Par3L to cell-cell contacts. Par3L isoforms also show differential binding to Par6. Despite these differences, the N-terminal region of Par3L, like that of Par3, can disrupt the formation of tight junctions when ectopically expressed in Madin-Darby canine kidney (MDCK) cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234671     DOI: 10.1016/s0378-1119(02)00681-9

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  30 in total

Review 1.  Widely conserved signaling pathways in the establishment of cell polarity.

Authors:  Luke Martin McCaffrey; Ian G Macara
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-08       Impact factor: 10.005

2.  The Par3/aPKC interaction is essential for end bud remodeling and progenitor differentiation during mammary gland morphogenesis.

Authors:  Luke Martin McCaffrey; Ian G Macara
Journal:  Genes Dev       Date:  2009-06-15       Impact factor: 11.361

3.  Genome-wide association study implicates PARD3B-based AIDS restriction.

Authors:  Jennifer L Troyer; George W Nelson; James A Lautenberger; Leslie Chinn; Carl McIntosh; Randall C Johnson; Efe Sezgin; Bailey Kessing; Michael Malasky; Sher L Hendrickson; Guan Li; Joan Pontius; Minzhong Tang; Ping An; Cheryl A Winkler; Sophie Limou; Sigrid Le Clerc; Olivier Delaneau; Jean-François Zagury; Hanneke Schuitemaker; Daniëlle van Manen; Jay H Bream; Edward D Gomperts; Susan Buchbinder; James J Goedert; Gregory D Kirk; Stephen J O'Brien
Journal:  J Infect Dis       Date:  2011-05-15       Impact factor: 5.226

Review 4.  Protein complexes that control renal epithelial polarity.

Authors:  Jay Pieczynski; Ben Margolis
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-12

Review 5.  Asymmetric Cell Division in T Lymphocyte Fate Diversification.

Authors:  Janilyn Arsenio; Patrick J Metz; John T Chang
Journal:  Trends Immunol       Date:  2015-10-20       Impact factor: 16.687

Review 6.  Phosphorylation of tight junction transmembrane proteins: Many sites, much to do.

Authors:  Christina M Van Itallie; James M Anderson
Journal:  Tissue Barriers       Date:  2017-10-30

Review 7.  PAR3-PAR6-atypical PKC polarity complex proteins in neuronal polarization.

Authors:  Sophie M Hapak; Carla V Rothlin; Sourav Ghosh
Journal:  Cell Mol Life Sci       Date:  2018-04-25       Impact factor: 9.261

Review 8.  The Mammalian Blood-Testis Barrier: Its Biology and Regulation.

Authors:  Dolores D Mruk; C Yan Cheng
Journal:  Endocr Rev       Date:  2015-09-10       Impact factor: 19.871

Review 9.  Par proteins and neuronal polarity.

Authors:  Ryan Insolera; She Chen; Song-Hai Shi
Journal:  Dev Neurobiol       Date:  2011-06       Impact factor: 3.964

10.  The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer.

Authors:  Marissa E Nolan; Victoria Aranda; Sangjun Lee; Balasubramanian Lakshmi; Srinjan Basu; D Craig Allred; Senthil K Muthuswamy
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.